Small cap pharmaceutical stock Adamas Pharmaceuticals Inc (NASDAQ: ADMS) is thefourteenth most shorted stock on theNASDAQ with short interest of 40.18% according to Highshortinterest.com. Adamas Pharmaceuticals portfolio includes: GOCOVRITM (amantadine) extended release capsules (previously ADS-5
On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap offshore oil and gas services stock PHI Inc (NASDAQ: PHIIK):
We’re a little bit late to the party here, but that’s ok – there’s still some meat left on the bone, so to speak. Were looking for the stock to continue on to the lower edge of a long-term (and bearish) trading range that should....More>>>
Source: ThinkstockUntil about 2008 or so, discussion about the future price of crude oil was directed by the concept of peak oil. That is, when does the world reach peak production, after which the price of crude will skyrocket. In less than a decade, the discussion is now focused on the concept of “peak demand,” the point at which global demand for crude begins to decline.
Making it in the finance field is tough. Making it as a woman is even tougher.
The eat what you kill mentality coupled with an often boys club work environment (think Susan Antila’s “Tales From The Boom Boom Room”) has been a less than stellar place for women to succeed. Today, women make up 16% of financial advisors across the country. Compare....More>>>
On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap acoustic technology stock LRAD Corp (NASDAQ: LRAD):
The Lrad short is a rather preemptive/presumptuous one, though worth the risk. The pros is the recent bump into the 100-day moving average line, and subsequent pullback from it. But, it’s the context of that action that means just as much. LRAD has been....More>>>
The last time I wrote on Micron (NASDAQ:MU) it was in tandem with Intel (NASDAQ:INTC) while riding down the DRAM cycle. That article was written in September of 2015 – things weren’t looking up for Micron, in fact they were still headed down.
I distinctly said I would be using Micron to play the turnaround in the industry. Now granted I played it a just a bit too early by initiating....More>>>
Related DIS 'Star Wars: Rogue One' Content Coming Exclusively To Twitter All The Post-Thanksgiving Holiday Deals From The 2 Largest Retailers Universal Theme Parks To Bring Nintendo Video-Game Worlds To Life (Investor’s Business Daily)
The biopharma and drug supply chain sectors outperformed the market last week, even as Trump administration officials pressed the president's blueprint to lower drug prices, with tough rhetoric for drugmakers and public shaming of pharmaceutical firms for supposedly blocking competition.
Since March 2009, the stock market has been virtually unstoppable. At one point in January 2018, all three major indexes -- the Dow Jones Industrial Average, S&P 500, and Nasdaq-- had essentially quadrupled from their Great Recession lows.
NanoString Technologies (NASDAQ: NSTG) is one of 91 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare NanoString Technologies to related businesses based on the strength of its earnings, p
Geron Corporation (NASDAQ:GERN), a clinical-stage cancer company, has grabbed the attention of growth investors due to its enormous upside potential. The short version of the story is that Geron is awaiting a critical continuation decision by partner Johnson & Johnson (NYSE:JNJ) in regards t
The average stock in the Nasdaq 100 is up just over 3% year to date. Using snapshots from our popular Trend Analyzer tool, below is a look at the best and worst performing stocks in the Nasdaq 100 so far in 2018.
At the top of the list is Netflix (NASDAQ:NFLX) with a year-to-date gain of